Maxillary sinus aspergillosis associated with migration of a dental implant: A case report

Katagiri, Wataru; Hashizume, Kosuke; Saito, Natsukaze; Funayama, Akinori; Kobayashi, Tadaharu

doi:10.1016/j.adoms.2021.100157

Cited by 5 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1][2][3][4][5] With dental implantation, both early and late inflammatory complications can develop. [6][7][8][9][10] The leading factors in the development of early post-implantation inflammatory complications are considered to be exogenous intrusion of microorganisms, exacerbation of endogenous inflammatory foci, traumatic factor of the surgery, overheating of the bone when drilling the bone bed. Among the late complications causes is the excessive load on the dental implant when it functions as supports for dentures, etc.…”

Section: Introductionmentioning

confidence: 99%

Prevention of Post-Implantation Inflammatory Complications

Tymofieiev

Ripa

Havlytiuk

et al. 2022

J. Diagn. Treat. Oral Maxillofac. Pathol.

View full text Add to dashboard Cite

Purpose: Currently, dental prosthetics on endosseous implants is used in most dental clinics of Ukraine. The incidence of inflammatory complications after the surgical stage of dental implantation, according to different authors, ranges from 0.4 to 5 percent. Therefore, many doctors during the surgical stage of dental implantation are looking for medications that simultaneously have both anti-inflammatory and analgesic effects. The purpose of this study is to determine the effectiveness of the treatment of early post-implantation complications when using the drug “Trachisan®” and compare its effectiveness with the traditionally used therapy. Materials and Methods: According to our observation, there were 24 patients aged from 20 to 56 years (1st observation group or main group). We prescribed Trachisan to these patients in the post-implantation period for 4 days. The control group consisted of 30 patients (2nd observation group or the control group), who were treated with traditional methods in the post-implantation period (Analgin tablets [metamizole sodium] and conventional antiseptic rinses). Results: Inflammatory complications in the 1st (main) group were not detected, and in the 2nd (control) group, inflammatory complications were diagnosed in 7 patients (23.3 percent), namely: mucositis – in 4 patients (13.3 percent) and peri-implantitis – in 3 patients (10 percent). Conclusions: Thus, the drug “Trachisan” should be recommended for widespread use in maxillofacial surgery after the surgical stage of dental implantation to prevent post-implantation inflammatory complications.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevention of Post-Implantation Inflammatory Complications

Tymofieiev

Ripa

Havlytiuk

et al. 2022

J. Diagn. Treat. Oral Maxillofac. Pathol.

View full text Add to dashboard Cite

show abstract

“…Which was gently relieved by an ENT specialist after endoscopic resection of the patient's area. And the implant was removed [21].…”

Section: Introductionmentioning

confidence: 99%

Infection of Aspergillous and Mucormycosis in Maxillary Region of a Woman with Diabetes After Covid19, A Case Report

Arian¹

2022

Prog Med Sci

View full text Add to dashboard Cite

Introduction: COVID as a common pandemic respiratory disease has affected many people in the world today. Symptoms of the disease include fever, cough, fatigue and lethargy, shortness of breath, lack of sense of smell and taste, etc. In people with weakened immune systems, especially if they have received corticosteroids, it can cause fungal diseases, especially with two types of aspergillus and mucormycosis, which can cause sinusitis, endocarditis, osteomyelitis and even death

show abstract